Log In
Print this Print this

levoleucovorin (Ready-to-Use Fusilev)

  Manage Alerts
Collapse Summary General Information
Company Spectrum Pharmaceuticals Inc.
DescriptionReady-to-Use formulation of an active isomer of the racemic leucovorin
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentApproved
Standard IndicationColorectal cancer
Indication DetailsTreat advanced metastatic colorectal cancer (mCRC)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today